Back

Provisional extracellular matrix signaling network regulates tumor lymphoneogenesis and response to immunotherapy

Lagal, D. J.; Hong, D.; Papadas, A.; Yacu, G. S.; Geatches, E.; Leschinsky, N.; Huang, Y.; Dou, Y.; Fields, M.; Gibbons, A.; Molina, E.; Pestonjamasp, K.; Toth, P. T.; Cicala, A.; Mamede, J.; Schneider, J.; Matkowskyj, K.; Deming, D. A.; Naik, S.; Asimakopoulos, F. A.

2026-09-29 immunology
10.64898/2026.09.24.753585 bioRxiv
Show abstract

Tertiary lymphoid structures (TLS) predict response to checkpoint inhibition, and conventional dendritic cells (cDC) are required to build and maintain them. What renders a niche permissive for their assembly is unknown: chemokines recruit the cellular constituents but do not specify how they organize. Here we show that the organizing signal is a matrix fragment. Proteolysis of the proteoglycan versican (VCAN) releases the matrikine versikine, constitutively in germinal center light zones and inducibly in tumor stroma. Versikine activates CD11b+ cDC and expands cDC1 to assemble TLS-archetypal triads, apposed DC: CD4+ T: CD8+ T units. Versikine-conditioned DC engage progenitor-exhausted CD8+ T cells (Tpex) and Th1-polarized follicular helper CD4+ T cells. Excess unproteolyzed VCAN inverts this toward DC-Treg crosstalk and Tpex loss. Versikine supplied as mRNA or recombinant protein sensitizes refractory tumors to PD-L1 blockade. VCAN proteolysis prospectively predicted outcomes after PD-1 blockade in metastatic colorectal cancer. Matrikines organize chemokine-recruited cells into functional immune niches.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.